Effects of Personalized Physical Activity and Psycho-Education Program on Patients With Chronic Hepatitis C Infection
Trial Snapshot
- Phase
- Not Applicable
- Enrollment
- 300
- Locations
- 1
- Primary Endpoint
- Effects of Activity and Education Program on Patients with Chronic Hepatitis C Infection
Study Overview
Brief Summary
This 4-year project will be guided by a biobehavioral model for the study of exercise interventions in two phases with the purposes to :
- explore the patients' physical activity preferences and develop doable activity lists during treatment period
- examine the changes of health-related physical fitness component over interferon treatment
- develop the Personalized Physical Activity and Psych-Education (PPAPE) Program and test its effects on decreasing fatigue, physical and psychological distress, and improving their health-related physical fitness and quality of life in patients with chronic hepatitis C receiving Interferon with Ribavirin Combination Therapy
- evaluate the outcome of the PPAPE program on increasing adherence to therapy, the sustained virological response (SVR) in 24 weeks after the end of treatment, and the time-consuming for education program during intervention.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Supportive Care
- Masking
- None
Eligibility Criteria
- Ages
- 20 Years to 70 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients with Chronic Hepatitis C Infection Receiving Interferon Therapy
- •Aged above 18
Exclusion Criteria
- Not provided
Arms & Interventions
Patient with HCV Infection
Personalized Physical Activity and Psycho-Education (PPAPE) Program will be tested on this group.
Intervention: Personalized Physical Activity and Psycho-Education (PPAPE) Program (Behavioral)
usual care
waiting list group with usual care
Outcomes
Primary Outcomes
Effects of Activity and Education Program on Patients with Chronic Hepatitis C Infection
Time Frame: 4-year project
Phase I of this project, the first and second year, the measurement time will be collected on the baseline (before treatment, T0), the 8 weeks (T1), 16 weeks (T2), and 24 weeks (T3) during treatment.
Secondary Outcomes
No secondary outcomes reported
